But in fact, research on personalized cancer vaccines, designed to help the immune system recognize and attack tumors, has been underway for at least a decade. Scientists have reported promising ...

“Unfortunately, the broader changes to Medicaid, combined with the current immigration climate, pose a significant risk of undermining these gains, potentially reversing the progress we’ve made in ...

Therapeutic vaccines train the immune system to recognize and attack malignant cells.

Galleri, a blood test that aims to detect over 50 cancers, illustrates the promise and popularity of an emerging technology to screen for cancer. Although the blood test is not approved by the Food ...

The Food and Drug Administration this month approved Optune Pax, from Novocure—a wearable tumor-treating fields (TTFields) device that uses electric fields to kill cancer cells—for the treatment of ...

“There are enough reports of it, enough interest in it, that we actually did — ivermectin, in particular — did engage in sort of a better preclinical study of its properties and its ability to kill ...

In December, the same research group published another study showing a survival benefit for small-cell lung cancer patients who received checkpoint inhibitors before mid-afternoon. A morning advantage ...

“Behind every diagnosis lies a unique human story—stories of grief, pain, healing, resilience, love and more. That’s why a people-centered approach to cancer care that fully integrates each individual ...

After decades of studies, no evidence links cell phone radiation to cancer or other health problems. Yet RFK Jr. wants to investigate.

The vaccine—now dubbed intismeran autogene (previously mRNA-4157 or V940)—plus Keytruda was associated with a 49% reduction in the risk of disease recurrence or death. The news release did not provide ...

In this episode of From Bench to Bedside and Beyond, endometrial cancer patient advocate Margie Wilson shares how community support helped power her recovery ...